Darutigenol

CAS No. 5940-00-1

Darutigenol( —— )

Catalog No. M18864 CAS No. 5940-00-1

Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 234 In Stock
2MG 136 In Stock
5MG 226 In Stock
10MG 340 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Darutigenol
  • Note
    Research use only, not for human use.
  • Brief Description
    Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
  • Description
    Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    5940-00-1
  • Formula Weight
    322.49
  • Molecular Formula
    C20H34O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@]1(CC[C@@H]2C(=C1)CC[C@H]1[C@]2(CC[C@H](C1(C)C)O)C)[C@H](CO)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen FF, et al. Molecularly imprinted polymer for the specific solid-phase extraction of kirenol from Siegesbeckia pubescens herbal extract. Talanta. 2012 Jan 30;89:505-12.
molnova catalog
related products
  • BW-A78U

    BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.

  • PDE IV-IN-1

    PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.

  • CI-1044

    CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.